No evidence for relevant impact of renal replacement therapy on clinical effect of erythromycin in critically ill patients with sepsis

Crit Care. 2023 Feb 23;27(1):70. doi: 10.1186/s13054-023-04359-z.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Continuous Renal Replacement Therapy*
  • Critical Illness / therapy
  • Erythromycin / therapeutic use
  • Humans
  • Renal Replacement Therapy / adverse effects
  • Sepsis* / therapy

Substances

  • Erythromycin